Lupin’s Goa facility may face regulatory action, says USFDA

  • Lupin has received a letter from the USFDA classifying the inspection conducted at its Goa facility between 28 Jan to 8 Feb as Official Action Indicated
  • Shares of Lupin today ended 1.38% higher at 743.70 apiece on the BSE

PTI
Updated30 May 2019, 09:20 PM IST

New Delhi: Drug maker Lupin on Thursday said the US health regulator has cautioned that the firm's Goa facility may be subject to regulatory or administrative action and it may withhold approval of any pending applications or supplements in which this facility is listed.

The company has received a letter from the US Food and Drug Administration (USFDA) classifying the inspection conducted at its Goa facility between 28 January to 8 February as Official Action Indicated (OAI), Lupin said in a regulatory filing.

"The USFDA has stated that this facility may be subject to regulatory or administrative action and that it may withhold approval of any pending applications or supplements in which this facility is listed," it added.

The Mumbai-based drug maker, however, said it does not believe that the classification would have an impact on supplies or the existing revenues from operations of this facility.

The company is in the process of sending further updates of its corrective actions to the USFDA and is hopeful of a positive outcome, it added.

Last month, the USFDA had classified the inspection conducted at the company's Pithampur (Indore) Unit-2 as OAI, which means approvals of pending applications or supplements from the site maybe withheld.

The US health regulator had also classified the inspection conducted at its Somerset (New Jersey) facility in December 2018 as OAI.

Shares of Lupin Thursday ended 1.38% higher at 743.70 apiece on the BSE.

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.MoreLess
First Published:30 May 2019, 09:20 PM IST
HomeCompaniesNewsLupin’s Goa facility may face regulatory action, says USFDA

Get Instant Loan up to ₹10 Lakh!

  • Employment Type

    Most Active Stocks

    Tata Steel

    157.75
    03:43 PM | 19 JUL 2024
    -8.6 (-5.17%)

    Tata Power

    414.15
    03:59 PM | 19 JUL 2024
    -15.85 (-3.69%)

    Bharat Electronics

    306.30
    03:45 PM | 19 JUL 2024
    -7.2 (-2.3%)

    Zee Entertainment Enterprises

    137.55
    03:57 PM | 19 JUL 2024
    -4.9 (-3.44%)
    More Active Stocks

    Market Snapshot

    • Top Gainers
    • Top Losers
    • 52 Week High

    Tata Teleservices Maharashtra

    102.11
    03:59 PM | 19 JUL 2024
    4.68 (4.8%)

    Rail Vikas Nigam

    614.00
    03:59 PM | 19 JUL 2024
    27.65 (4.72%)

    Jubilant Pharmova

    752.25
    03:43 PM | 19 JUL 2024
    25.3 (3.48%)

    One 97 Communications

    458.70
    03:55 PM | 19 JUL 2024
    13.65 (3.07%)
    More from Top Gainers

    Recommended For You

      More Recommendations

      Gold Prices

      • 24K
      • 22K
      Bangalore
      75,217.000.00
      Chennai
      75,657.000.00
      Delhi
      74,485.000.00
      Kolkata
      74,485.000.00

      Fuel Price

      • Petrol
      • Diesel
      Bangalore
      102.86/L0.00
      Chennai
      100.75/L0.00
      Kolkata
      104.95/L0.00
      New Delhi
      94.72/L0.00
      OPEN IN APP
      HomeMarketsCibilPremiumBudget